# Mindray to acquire control of APT Medical for $927M

Mindray announced its intention to acquire control of APT Medical (688617.SH), a Chinese cardiovascular medical device company, for 6.65 billion yuan ($927 million) through a share transfer and voting rights waiver. Mindray will become the largest and controlling shareholder with 24.61% of APT Medical's equity.

- Type: Acquisition
- Announced: 2024-01-29
- Where: Shenzhen, China
- Value: $927.0M (6.65B CNY)
- Status: announced
- Products: cardiovascular medical devices, cardiac electrophysiology products, coronary artery access products, peripheral vascular intervention products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Mindray](https://endata.com/companies/48008.md) (acquirer)
- [APT Medical](https://endata.com/companies/75301.md) (target)

## Sources

- [mindray.com](https://www.mindray.com/en/media-center/news/mindray-plans-927-million-deal-control-apt-medical), 2024-01-29: "Mindray announced its intention to acquire control of APT Medical (688617.SH), a medical device company listed on the Sci-Tech Innovation Board of Shanghai Stock Exchange, using its own funds of 6.65 billion yuan ($927 million)."
- [hospimedica.com](https://www.hospimedica.com/business/articles/294800136/mindray-to-acquire-chinese-medical-device-company-apt-medical.html), 2024-02-05: "Mindray will acquire control of APT Medical using its own funds of USD 927 million using a combination of share transfer by agreement and waiver of voting rights."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.